JMAC Enterprises’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$861K Hold
11,000
0.15% 71
2026
Q1
$953K Hold
11,000
0.18% 65
2025
Q4
$1.06M Buy
11,000
+1,900
+21% +$185K 0.2% 59
2025
Q3
$867K Sell
9,100
-1,800
-17% -$165K 0.17% 70
2025
Q2
$950K Buy
10,900
+67
+0.6% +$5.68K 0.2% 61
2025
Q1
$973K Sell
10,833
-274
-2% -$24.5K 0.23% 56
2024
Q4
$887K Buy
11,107
+600
+6% +$51.9K 0.14% 105
2024
Q3
$946K Buy
10,507
+714
+7% +$60.1K 0.15% 102
2024
Q2
$771K Hold
9,793
0.14% 110
2024
Q1
$853K Buy
9,793
+900
+10% +$76.8K 0.16% 99
2023
Q4
$733K Buy
8,893
+100
+1% +$7.62K 0.16% 106
2023
Q3
$689K Buy
8,793
+800
+10% +$67K 0.17% 106
2023
Q2
$704K Buy
7,993
+1,300
+19% +$112K 0.17% 100
2023
Q1
$540K Buy
6,693
+1,480
+28% +$121K 0.14% 112
2022
Q4
$405K Sell
5,213
-2,000
-28% -$162K 0.11% 128
2022
Q3
$582K Buy
7,213
+2,400
+50% +$216K 0.16% 119
2022
Q2
$432K Buy
4,813
+100
+2% +$10.1K 0.11% 133
2022
Q1
$523K Sell
4,713
-100
-2% -$10.6K 0.12% 124
2021
Q4
$498K Buy
+4,813
New +$557K 0.12% 125

Other funds holding MDT

JMAC Enterprises's MDT Position: Q2 2026 in Review

JMAC Enterprises held its Medtronic (MDT) position steady in Q2 2026 at 11,000 shares worth $861K. The position accounts for 0.15% of the portfolio, ranked #71.

JMAC Enterprises first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.06M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • JMAC Enterprises held 11,000 shares of Medtronic worth $861K as of Q2 2026.
  • JMAC Enterprises left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.15% of JMAC Enterprises's portfolio in Q2 2026, its #71 holding.
  • JMAC Enterprises first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • JMAC Enterprises's Medtronic position peaked at $1.06M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.